与基于利妥昔单抗的细胞毒性疗法相关的卡波西肉瘤
Kaposi sarcoma associated with rituximab-based cytotoxic therapy.
作者信息
Alkan Ali, Yaşar Arzu, Toprak Serhat
机构信息
Department of Internal Medicine, Medical Oncology Unit, Muğla S|tk| Koçman University School of Medicine, Muğla, Turkey.
Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey.
出版信息
J Oncol Pharm Pract. 2020 Jan;26(1):220-223. doi: 10.1177/1078155219835592. Epub 2019 Mar 9.
Kaposi sarcoma (KS) is a low-grade mesenchymal angioproliferative disease, mostly observed in immune compromised patients. KS is mostly encountered in HIV-positive or organ transplant patients. The drugs causing immunosuppression have also been associated with KS. Here, we present a KS experience associated with rituximab-based therapy.
卡波西肉瘤（KS）是一种低度间质性血管增殖性疾病，多见于免疫功能低下的患者。KS多见于HIV阳性患者或器官移植患者。导致免疫抑制的药物也与KS有关。在此，我们介绍一例与利妥昔单抗治疗相关的KS病例。
Zotero 插件